Diagnosis and therapy of cancer using SGP28-related molecules
US6835822B1 · kind B1 · utility
3Cited by
0References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 27, 2000 |
| Grant date | Dec 28, 2004 |
| Priority date | — |
| Expiry date | Jan 5, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/158
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods and compositions for the diagnosis and therapy of prostate cancer which utilize isolated polynucleotides corresponding to the human SGP28 gene, proteins encoded by the SGP28 gene and fragments thereof, and antibodies capable of specifically recognizing and binding to SGP28 proteins.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.